North China Pharmaceutical Group Co., Ltd., founded in 1953, is a large-scale modern pharmaceutical enterprise focusing on the production and sales of antibiotics/vitamins and nutritional health products
North China Pharmaceutical Group Co., Ltd. (hereinafter referred to as Huayao Group) is one of China's chemical and pharmaceutical enterprises, located in Shijiazhuang, the capital of Hebei Province. The predecessor of the North China Pharmaceutical Factory was a key construction project during China's "First Five-Year Plan", which began to be built in June 1953 and completed and put into operation in June 1958, creating a history of large-scale production of antibiotics in China and making important contributions to changing the situation of lack of medical treatment and medicine in China. In 1992, North China Pharmaceutical Co., Ltd. was reorganized and established, and in 1994, it was listed on the Shanghai Stock Exchange. In January 1996, North China Pharmaceutical Factory was officially restructured into a wholly state-owned company, North China Pharmaceutical Group Co., Ltd. In June 2009, with the approval of the Hebei Provincial Government, Jizhong Energy Group reorganized Huayao Group.
Over the years, Huayao Group has continued to innovate, operated steadily, gradually expanded, expanded its business scope, maintained excellent development performance, and its main economic indicators have always been in the forefront of the domestic industry. As of the end of 2014, Huayao Group has total assets of 18 billion yuan, more than 20,000 employees, and more than 40 subsidiaries (branches), with more than 700 specifications in five major sectors, including antibiotics such as penicillin and cephalosporins, biotechnology drugs, new preparations, biological agricultural and veterinary drugs, vitamins and nutritional health products. The completion and commissioning of the new park project represented by new cephalosporin and new preparation marks the opening of a new chapter in the construction of a modern international first-class pharmaceutical group by Huayao Group.
Technological advantages
As one of the first batch of 6 national technological innovation pilot enterprises and the industrialization base of the national "863" high-tech research and development plan, Huayao Group has a team of more than 4,000 professional and technical personnel, and its independent research and development capabilities are at the forefront of the industry. 19 National Science and Technology Progress Awards.
Quality advantage
Since the early 80s, Huayao Group has implemented total quality management (TQM), established a sound and effective quality management system, and implemented all aspects of the production process in accordance with GMP standards, and has a high quality reputation in the domestic and foreign markets. In 1986, it won the "National Quality Management Award" in the pharmaceutical industry. In 2000, it passed the ISO9001 quality management system certification, and in 2003, it passed the ISO14001 environmental management system certification. At present, it has passed the US FDA certification, obtained the EU COS certificate and other international high-end certification products more than 30, 150 main product production lines have passed the new version of GMP certification, and obtained 47 new GMP certificates, walking in the forefront of the industry.
Development strategy
In the next few years, Huayao Group will adhere to the guidance of the scientific concept of development, adhering to the corporate tenet of "human health first, quality always first", and in accordance with the development strategy of "overall planning and integration, innovation, optimization and upgrading, and refinement and strengthening", we will refine and strengthen the traditional advantageous anti-infective drug sector, improve and expand the modern biomedical sector, and actively develop professional treatment fields, agricultural and veterinary drugs, health and pharmaceutical logistics sectors, and strive to build the enterprise into a "leading innovation, intensive and efficient, open and win-win, Harmonious and affluent", Xinhua Pharmaceutical has built itself into a close-knit, high-efficiency and sustainable leading modern pharmaceutical group in China.
